Since its founding in 2018, Eric Chow & Co., in Association with Commerce & Finance Law Offices has made strong in-roads into the Hong Kong market, leveraging very effectively off the firm’s association with Red Circle full-service Chinese firm Commerce & Finance Law Offices to provide cohesive ‘solutions-oriented advice’ to issuers and underwriters listing on the HKEX. Founding partner Eric Chow is ’technical and responsive’, and has been involved in a number of high-profile healthcare listings alongside the ‘hands-on’ Brandon Chow.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The team provides solutions-oriented advice.'
- 'Eric Chow is technical and responsive.'
- 'Brandon Chow is hands on and ready to provide viable solutions to issues in the IPO deal.'
- 'Winnie Tang is an up and coming lawyer that always provides timely and practical advice to deal with listing issues.'
Key clients
- Concord Healthcare Group Co., Ltd.
- China Securities (International) Corporate Finance Company Limited
- China Merchants Securities (HK) Co., Limited
- Beijing Luzhu Biotechnology Co., Ltd.
- CEB International Capital Corporation Limited
- Aidigong Maternal & Child Health Limited
- Immunotech Biopharm Ltd.
- China Nonferrous Mining Corporation Limited (HKEx: 1258)
Work highlights
- Advised Concord Healthcare Group Co. on its $82.9m global offering and IPO of H-shares on the Main Board of the Hong Kong Stock Exchange.
- Advised the joint sponsors on the $32.05m global offering and IPO of H-shares of Pu’er Lancang Ancient Tea Co. on the Main Board of the Hong Kong Stock Exchange.
- Advised Beijing Luzhu Biotechnology Co on its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited.
Practice head
The lawyer(s) leading their teams.
Eric Chow